1. Repository of OAI
Ελληνικά   English  
Saved Searches

Discover

Search


Current filters:

Clear current filters  or Add more filters

View Option


Results 21-30 of 35 (Search time: 0.007 seconds).

  The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia (Journal article)

  The Effects of Hypolipidemic Treatment on Lipoprotein-Associated Phospholipase A2 in Patients with Mixed Hyperlipidemia (Journal article)

  Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) activity in healthy obese women (Journal article)

  Effects of Fenofibrate and Orlistat, Alone or in Combination, on Plasma Visfatin Levels in Subjects with Metabolic Syndrome (Journal article)

  Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemia (Journal article)

  Effects of a 6-month infliximab treatment on plasma levels of leptin and adiponectin in patients with rheumatoid arthritis (Journal article)

  Effects of ezetimibe, either alone or in combination with atorvastatin, on serum visfatin levels: a pilot study (Journal article)

  Effects of orlistat and fenofibrate combination on LDL phenotype in overweight and obese patients with metabolic syndrome. The fenorli study (Journal article)

  Effects of Orlistat and Fenofibrate, Alone or in Combination, on Plasma Apolipoprotein C-Ii and C-Iii Levels in Metabolic Syndrome Patients (Journal article)

  Effects of combination of orlistat and micronised fenofibrate on lipid profile in overweight and obese patients with metabolic syndrome (Journal article)